The effect of low-dose marine n-3 fatty acids on the biosynthesis of pro-inflammatory 5-lipoxygenase pathway metabolites in overweight subjects: A randomized controlled trial

Marine n-3 polyunsaturated fatty acids (PUFA) have a variety of anti-inflammatory properties. This study evaluated the effect of n-3 PUFA in a low, but recommended cardioprotective dosage on the formation of 5-lipoxygenase pathway metabolites in overweight subjects. Fifty subjects were randomized to...

Full description

Saved in:
Bibliographic Details
Published inProstaglandins, leukotrienes and essential fatty acids Vol. 87; no. 1; pp. 43 - 48
Main Authors Nielsen, M.S., Gammelmark, A., Madsen, T., Obel, T., Aardestrup, I., Schmidt, E.B.
Format Journal Article
LanguageEnglish
Published Scotland Elsevier Ltd 01.07.2012
Subjects
Online AccessGet full text
ISSN0952-3278
1532-2823
1532-2823
DOI10.1016/j.plefa.2012.05.009

Cover

Abstract Marine n-3 polyunsaturated fatty acids (PUFA) have a variety of anti-inflammatory properties. This study evaluated the effect of n-3 PUFA in a low, but recommended cardioprotective dosage on the formation of 5-lipoxygenase pathway metabolites in overweight subjects. Fifty subjects were randomized to 1.1g of n-3 PUFA or olive oil for 6 weeks. Leukotriene B4 formation decreased by 14% in the n-3 PUFA group which proved to be significant within the group (p=0.005) but not between groups (p=0.25). The formation of 5-hydroxyeicosatetraenoic acid (5-HETE) did not differ significantly between the groups. In the n-3 PUFA group, both 5-hydroxyeicosapentaenoic (5-HEPE) acid and leukotriene B5 increased significantly compared to the control group (p<0.001). In conclusion, we did not observe any significant net anti-inflammatory effect on the 5-lipoxygenase pathway from a daily supplement of 1.1g marine n-3 PUFA for 6 weeks.
AbstractList Abstract Introduction Marine n-3 polyunsaturated fatty acids (PUFA) have a variety of anti-inflammatory properties. This study evaluated the effect of n-3 PUFA in a low, but recommended cardioprotective dosage on the formation of 5-lipoxygenase pathway metabolites in overweight subjects. Materials and methods Fifty subjects were randomized to 1.1 g of n-3 PUFA or olive oil for 6 weeks. Results Leukotriene B4 formation decreased by 14% in the n-3 PUFA group which proved to be significant within the group ( p =0.005) but not between groups ( p =0.25). The formation of 5-hydroxyeicosatetraenoic acid (5-HETE) did not differ significantly between the groups. In the n-3 PUFA group, both 5-hydroxyeicosapentaenoic (5-HEPE) acid and leukotriene B5 increased significantly compared to the control group ( p <0.001). Conclusion In conclusion, we did not observe any significant net anti-inflammatory effect on the 5-lipoxygenase pathway from a daily supplement of 1.1 g marine n-3 PUFA for 6 weeks.
Marine n-3 polyunsaturated fatty acids (PUFA) have a variety of anti-inflammatory properties. This study evaluated the effect of n-3 PUFA in a low, but recommended cardioprotective dosage on the formation of 5-lipoxygenase pathway metabolites in overweight subjects.INTRODUCTIONMarine n-3 polyunsaturated fatty acids (PUFA) have a variety of anti-inflammatory properties. This study evaluated the effect of n-3 PUFA in a low, but recommended cardioprotective dosage on the formation of 5-lipoxygenase pathway metabolites in overweight subjects.Fifty subjects were randomized to 1.1g of n-3 PUFA or olive oil for 6 weeks.MATERIALS AND METHODSFifty subjects were randomized to 1.1g of n-3 PUFA or olive oil for 6 weeks.Leukotriene B(4) formation decreased by 14% in the n-3 PUFA group which proved to be significant within the group (p=0.005) but not between groups (p=0.25). The formation of 5-hydroxyeicosatetraenoic acid (5-HETE) did not differ significantly between the groups. In the n-3 PUFA group, both 5-hydroxyeicosapentaenoic (5-HEPE) acid and leukotriene B(5) increased significantly compared to the control group (p<0.001).RESULTSLeukotriene B(4) formation decreased by 14% in the n-3 PUFA group which proved to be significant within the group (p=0.005) but not between groups (p=0.25). The formation of 5-hydroxyeicosatetraenoic acid (5-HETE) did not differ significantly between the groups. In the n-3 PUFA group, both 5-hydroxyeicosapentaenoic (5-HEPE) acid and leukotriene B(5) increased significantly compared to the control group (p<0.001).In conclusion, we did not observe any significant net anti-inflammatory effect on the 5-lipoxygenase pathway from a daily supplement of 1.1g marine n-3 PUFA for 6 weeks.CONCLUSIONIn conclusion, we did not observe any significant net anti-inflammatory effect on the 5-lipoxygenase pathway from a daily supplement of 1.1g marine n-3 PUFA for 6 weeks.
Marine n-3 polyunsaturated fatty acids (PUFA) have a variety of anti-inflammatory properties. This study evaluated the effect of n-3 PUFA in a low, but recommended cardioprotective dosage on the formation of 5-lipoxygenase pathway metabolites in overweight subjects. Fifty subjects were randomized to 1.1g of n-3 PUFA or olive oil for 6 weeks. Leukotriene B4 formation decreased by 14% in the n-3 PUFA group which proved to be significant within the group (p=0.005) but not between groups (p=0.25). The formation of 5-hydroxyeicosatetraenoic acid (5-HETE) did not differ significantly between the groups. In the n-3 PUFA group, both 5-hydroxyeicosapentaenoic (5-HEPE) acid and leukotriene B5 increased significantly compared to the control group (p<0.001). In conclusion, we did not observe any significant net anti-inflammatory effect on the 5-lipoxygenase pathway from a daily supplement of 1.1g marine n-3 PUFA for 6 weeks.
Marine n-3 polyunsaturated fatty acids (PUFA) have a variety of anti-inflammatory properties. This study evaluated the effect of n-3 PUFA in a low, but recommended cardioprotective dosage on the formation of 5-lipoxygenase pathway metabolites in overweight subjects. Fifty subjects were randomized to 1.1g of n-3 PUFA or olive oil for 6 weeks. Leukotriene B(4) formation decreased by 14% in the n-3 PUFA group which proved to be significant within the group (p=0.005) but not between groups (p=0.25). The formation of 5-hydroxyeicosatetraenoic acid (5-HETE) did not differ significantly between the groups. In the n-3 PUFA group, both 5-hydroxyeicosapentaenoic (5-HEPE) acid and leukotriene B(5) increased significantly compared to the control group (p<0.001). In conclusion, we did not observe any significant net anti-inflammatory effect on the 5-lipoxygenase pathway from a daily supplement of 1.1g marine n-3 PUFA for 6 weeks.
Author Schmidt, E.B.
Aardestrup, I.
Madsen, T.
Nielsen, M.S.
Gammelmark, A.
Obel, T.
Author_xml – sequence: 1
  givenname: M.S.
  surname: Nielsen
  fullname: Nielsen, M.S.
  email: mrsn@rn.dk
– sequence: 2
  givenname: A.
  surname: Gammelmark
  fullname: Gammelmark, A.
– sequence: 3
  givenname: T.
  surname: Madsen
  fullname: Madsen, T.
– sequence: 4
  givenname: T.
  surname: Obel
  fullname: Obel, T.
– sequence: 5
  givenname: I.
  surname: Aardestrup
  fullname: Aardestrup, I.
– sequence: 6
  givenname: E.B.
  surname: Schmidt
  fullname: Schmidt, E.B.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22748976$$D View this record in MEDLINE/PubMed
BookMark eNqFks1u1DAUhS1URKeFJ0BCXrLJ4J8kk4CoVFX8SZVYUNaWY193PDj2YHs6hIfiGXGYwqISmpXv4nzH9jn3DJ344AGh55QsKaHtq81y68DIJSOULUmzJKR_hBa04axiHeMnaEH6hlWcrbpTdJbShhDCKK2foFPGVnXXr9oF-nWzBgzGgMo4GOzCvtIhAR5ltB6wrzg2MucJS2V1wsHjXIDBhjT5MiWbZmwbQ2W9cXIcZQ5xwk3l7Db8mG7By-K2lXm9lxMeIcshOJshYetxuIO4B3u7zjjthk15Q3qNL3GUXofR_gSNVfA5BufKmKOV7il6bKRL8Oz-PEdf37-7ufpYXX_-8Onq8rpSddvmqjGGE6M5NJ1RLa2Zamo99K3RRLFeadryoW_artOs72jDyCALwOVAoNNQ5nP08uBbfvZ9BymL0SYFzkkPYZcEJSVVzuu2L9IX99LdMIIW22hLeJP4m3ER8INAxZBSBPNPQomYmxQb8adJMTcpSCNKk4XqH1DKZpntHIi07gj79sBCiejOQhRJWfAKtI0lZKGDPcJfPOCVs94q6b7BBGkTdtGX9AUVqTDiy7xn85pRVlas60kxePN_g6PX_wYCRedW
CitedBy_id crossref_primary_10_1002_14651858_CD012815_pub2
crossref_primary_10_1002_14651858_CD012815_pub3
crossref_primary_10_1002_mnfr_201300321
crossref_primary_10_1038_s41598_017_04474_2
crossref_primary_10_2983_035_037_0403
crossref_primary_10_1194_jlr_M047357
crossref_primary_10_1016_j_bbalip_2018_06_011
crossref_primary_10_3390_nu6104043
crossref_primary_10_1111_joim_12442
crossref_primary_10_1371_journal_pone_0094836
crossref_primary_10_1016_j_nutres_2013_04_012
crossref_primary_10_1016_j_metabol_2017_01_034
crossref_primary_10_1016_j_prostaglandins_2018_03_002
crossref_primary_10_1017_jns_2021_46
crossref_primary_10_3390_nu9050513
crossref_primary_10_3945_jn_117_247569
Cites_doi 10.2459/01.JCM.0000289269.98105.65
10.1016/j.clnu.2008.10.012
10.1046/j.1464-5491.2001.00410.x
10.1172/JCI111612
10.1097/01.hjr.0000277983.23934.c9
10.1007/BF02562283
10.1016/S0021-9258(18)98347-X
10.1007/s11745-999-0369-5
10.1074/jbc.M203194200
10.1074/jbc.M109.004861
10.1017/S0007114508923692
10.1016/j.nutres.2011.12.007
10.1161/01.ATV.0000057393.97337.AE
10.1093/ajcn/83.2.456S
10.1136/bmj.311.6998.158
10.1016/0090-6980(84)90075-3
10.1056/NEJM198505093121903
10.1016/0748-5514(85)90121-7
10.1097/MCO.0b013e32834777fa
10.1016/S0022-2275(20)41095-8
10.1378/chest.129.1.39
10.1161/01.CIR.0000052939.59093.45
10.1111/j.1365-2362.2010.02371.x
10.1038/sj.ki.5000291
10.1124/jpet.109.157891
10.1007/s10557-008-6140-9
10.1159/000419307
10.4049/jimmunol.178.6.3912
10.1007/BF00915380
10.1016/j.plefa.2011.04.004
ContentType Journal Article
Copyright 2012 Elsevier Ltd
Elsevier Ltd
Copyright © 2012 Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2012 Elsevier Ltd
– notice: Elsevier Ltd
– notice: Copyright © 2012 Elsevier Ltd. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.plefa.2012.05.009
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1532-2823
EndPage 48
ExternalDocumentID 22748976
10_1016_j_plefa_2012_05_009
S0952327812000890
1_s2_0_S0952327812000890
Genre Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: The Spar Nord Foundation
– fundername: Dr. Heinrich Kopps Foundation
– fundername: The Obelske Family Foundation
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
3O-
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABGSF
ABMAC
ABMZM
ABUDA
ABWVN
ABXDB
ACDAQ
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADUVX
ADVLN
AEBSH
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDZ
HMK
HMO
HVGLF
HZ~
IHE
J1W
KOM
LZ1
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OB0
ON-
OZT
P-8
P-9
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
UHS
WUQ
Z5R
ZGI
~G-
AACTN
AFKWA
AJOXV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AJBFU
DOVZS
EFLBG
LCYCR
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c466t-5ff30fd3e58fc6142c54db96fd0c29cd163b95688d2981520baf303ab0e8deaf3
IEDL.DBID AIKHN
ISSN 0952-3278
1532-2823
IngestDate Fri Sep 05 09:38:39 EDT 2025
Thu Apr 03 07:07:03 EDT 2025
Thu Apr 24 23:07:38 EDT 2025
Tue Jul 01 00:37:14 EDT 2025
Fri Feb 23 02:22:30 EST 2024
Sun Feb 23 10:19:07 EST 2025
Tue Aug 26 20:26:23 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Leukotrienes
Marine n-3 polyunsaturated fatty acids
5-Lipoxygenase
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright © 2012 Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c466t-5ff30fd3e58fc6142c54db96fd0c29cd163b95688d2981520baf303ab0e8deaf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
PMID 22748976
PQID 1027833469
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_1027833469
pubmed_primary_22748976
crossref_primary_10_1016_j_plefa_2012_05_009
crossref_citationtrail_10_1016_j_plefa_2012_05_009
elsevier_sciencedirect_doi_10_1016_j_plefa_2012_05_009
elsevier_clinicalkeyesjournals_1_s2_0_S0952327812000890
elsevier_clinicalkey_doi_10_1016_j_plefa_2012_05_009
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-07-01
PublicationDateYYYYMMDD 2012-07-01
PublicationDate_xml – month: 07
  year: 2012
  text: 2012-07-01
  day: 01
PublicationDecade 2010
PublicationPlace Scotland
PublicationPlace_xml – name: Scotland
PublicationTitle Prostaglandins, leukotrienes and essential fatty acids
PublicationTitleAlternate Prostaglandins Leukot Essent Fatty Acids
PublicationYear 2012
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Lean, Han, Morrison (bib16) 1995; 311
Hosoi, Koguchi, Sugikawa, Chikada, Ogawa, Tsuda (bib29) 2002; 277
Mickleborough, Lindley, Ionescu, Fly (bib13) 2006; 129
Giouleka, Papatheodorou, Lyberopoulos, Karakatsani, Alchanatis, Roussos (bib32) 2011; 41
Graham, Atar, Borch-Johnsen, Boysen, Burell, Cifkova (bib1) 2007; 14
van Kuijk, Thomas, Stephens, Dratz (bib17) 1985; 1
Moreno (bib22) 2009; 331
Sperling (bib19) 1991; 66
National Food Institute—Technical University of Denmark (DTU). Available from
Mickleborough, Tecklenburg, Montgomery, Lindley (bib24) 2009; 28
Heidel, Taylor, Laegreid, Silflow, Liggitt, Leid (bib27) 1989; 134
Taccone-Gallucci, Manca-di-Villahermosa, Battistini, Stuffler, Tedesco, Maccarrone (bib25) 2006; 69
Martinez-Clemente, Claria, Titos. (bib5) 2011; 14
Gammelmark, Madsen, Varming, Lundbye-Christensen, Schmidt (bib14) 2012; 32
Terano, Salmon, Moncada (bib23) 1984; 27
Kelley, Taylor, Nelson, Schmidt, Ferretti, Erickson (bib8) 1999; 34
Lee, Mencia-Huerta, Shih, Corey, Lewis, Austen (bib30) 1984; 74
Libby (bib3) 2006; 83
Lossl, Skou, Christensen, Schmidt. (bib9) 1999; 34
Arita, Ohira, Sun, Elangovan, Chiang, Serhan. (bib34) 2007; 178
Pearson, Mensah, Alexander, Anderson, Cannon, Criqui (bib33) 2003; 107
Masson, Latini, Tacconi, Bernasconi (bib21) 2007; 8
Back. (bib4) 2009; 23
Payan, Wong, Chernov-Rogan, Valone, Pickett, Blake (bib11) 1986; 6
Kris-Etherton, Harris, Appel, AHA Nutrition Committee, American Heart Association (bib2) 2003; 23
.
Lee, Hoover, Williams, Sperling, Ravalese, Spur (bib12) 1985; 312
Massaro, Scoditti, Carluccio, Campana, De Caterina. (bib20) 2010; 56
Powell, Gravel, Gravelle (bib31) 1995; 36
Stanke-Labesque, Moliere, Bessard, Laville, Vericel, Lagarde (bib7) 2008; 100
Sampson, Davies, Brown, Morgan, Richardson, James (bib10) 2001; 18
Maaloe, Schmidt, Svensson, Aardestrup, Christensen. (bib26) 2011; 85
Weaver, Ivester, Seeds, Case, Arm, Chilton (bib6) 2009; 284
Report of IUPAC Working Group (bib18) 1987
Powell, Gravel, MacLeod, Mills, Hashefi (bib28) 1993; 268
10.1016/j.plefa.2012.05.009_bib15
Mickleborough (10.1016/j.plefa.2012.05.009_bib24) 2009; 28
Maaloe (10.1016/j.plefa.2012.05.009_bib26) 2011; 85
Weaver (10.1016/j.plefa.2012.05.009_bib6) 2009; 284
Report of IUPAC Working Group (10.1016/j.plefa.2012.05.009_bib18) 1987
Masson (10.1016/j.plefa.2012.05.009_bib21) 2007; 8
Sampson (10.1016/j.plefa.2012.05.009_bib10) 2001; 18
Massaro (10.1016/j.plefa.2012.05.009_bib20) 2010; 56
Kris-Etherton (10.1016/j.plefa.2012.05.009_bib2) 2003; 23
Back. (10.1016/j.plefa.2012.05.009_bib4) 2009; 23
Hosoi (10.1016/j.plefa.2012.05.009_bib29) 2002; 277
Libby (10.1016/j.plefa.2012.05.009_bib3) 2006; 83
Lee (10.1016/j.plefa.2012.05.009_bib12) 1985; 312
Powell (10.1016/j.plefa.2012.05.009_bib31) 1995; 36
Stanke-Labesque (10.1016/j.plefa.2012.05.009_bib7) 2008; 100
Lossl (10.1016/j.plefa.2012.05.009_bib9) 1999; 34
Kelley (10.1016/j.plefa.2012.05.009_bib8) 1999; 34
Lee (10.1016/j.plefa.2012.05.009_bib30) 1984; 74
van Kuijk (10.1016/j.plefa.2012.05.009_bib17) 1985; 1
Graham (10.1016/j.plefa.2012.05.009_bib1) 2007; 14
Martinez-Clemente (10.1016/j.plefa.2012.05.009_bib5) 2011; 14
Taccone-Gallucci (10.1016/j.plefa.2012.05.009_bib25) 2006; 69
Arita (10.1016/j.plefa.2012.05.009_bib34) 2007; 178
Terano (10.1016/j.plefa.2012.05.009_bib23) 1984; 27
Sperling (10.1016/j.plefa.2012.05.009_bib19) 1991; 66
Gammelmark (10.1016/j.plefa.2012.05.009_bib14) 2012; 32
Moreno (10.1016/j.plefa.2012.05.009_bib22) 2009; 331
Mickleborough (10.1016/j.plefa.2012.05.009_bib13) 2006; 129
Pearson (10.1016/j.plefa.2012.05.009_bib33) 2003; 107
Heidel (10.1016/j.plefa.2012.05.009_bib27) 1989; 134
Powell (10.1016/j.plefa.2012.05.009_bib28) 1993; 268
Payan (10.1016/j.plefa.2012.05.009_bib11) 1986; 6
Lean (10.1016/j.plefa.2012.05.009_bib16) 1995; 311
Giouleka (10.1016/j.plefa.2012.05.009_bib32) 2011; 41
References_xml – volume: 6
  start-page: 402
  year: 1986
  end-page: 410
  ident: bib11
  article-title: Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid
  publication-title: J. Clin. Immunol.
– volume: 32
  start-page: 15
  year: 2012
  end-page: 23
  ident: bib14
  article-title: Low-dose fish oil supplementation increases serum adiponectin without affecting inflammatory markers in overweight subjects
  publication-title: Nutr. Res.
– volume: 134
  start-page: 671
  year: 1989
  end-page: 676
  ident: bib27
  article-title: In vivo chemotaxis of bovine neutrophils induced by 5-lipoxygenase metabolites of arachidonic and eicosapentaenoic acid
  publication-title: Am. J. Pathol.
– volume: 277
  start-page: 31459
  year: 2002
  end-page: 31465
  ident: bib29
  article-title: Identification of a novel human eicosanoid receptor coupled to G(i/o)
  publication-title: J. Biol. Chem.
– volume: 23
  start-page: 41
  year: 2009
  end-page: 48
  ident: bib4
  article-title: Leukotriene signaling in atherosclerosis and ischemia
  publication-title: Cardiovasc. Drugs Ther.
– volume: 41
  start-page: 30
  year: 2011
  end-page: 38
  ident: bib32
  article-title: Body mass index is associated with leukotriene inflammation in asthmatics
  publication-title: Eur. J. Clin. Invest.
– volume: 311
  start-page: 158
  year: 1995
  end-page: 161
  ident: bib16
  article-title: Waist circumference as a measure for indicating need for weight management
  publication-title: Br. Med. J.
– volume: 28
  start-page: 71
  year: 2009
  end-page: 77
  ident: bib24
  article-title: Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic alveolar macrophage cells
  publication-title: Clin. Nutr.
– volume: 36
  start-page: 2590
  year: 1995
  end-page: 2598
  ident: bib31
  article-title: Formation of a 5-oxo metabolite of 5,8,11,14,17-eicosapentaenoic acid and its effects on human neutrophils and eosinophils
  publication-title: J. Lipid Res.
– volume: 312
  start-page: 1217
  year: 1985
  end-page: 1224
  ident: bib12
  article-title: Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function
  publication-title: N. Engl. J. Med.
– volume: 85
  start-page: 37
  year: 2011
  end-page: 41
  ident: bib26
  article-title: The effect of n-3 polyunsaturated fatty acids on leukotriene B(4) and leukotriene B(5) production from stimulated neutrophil granulocytes in patients with chronic kidney disease
  publication-title: Prostaglandins Leukot. Essent. Fatty Acids
– volume: 268
  start-page: 9280
  year: 1993
  end-page: 9286
  ident: bib28
  article-title: Stimulation of human neutrophils by 5-oxo-6,8,11,14-eicosatetraenoic acid by a mechanism independent of the leukotriene B4 receptor
  publication-title: J. Biol. Chem.
– year: 1987
  ident: bib18
  publication-title: IUPAC Method 2.301. IUPAC Standard Methods for Analysis of Oils, Fats and Derivatives
– volume: 66
  start-page: 391
  year: 1991
  end-page: 400
  ident: bib19
  article-title: Effects of dietary fish oil on leukocyte leukotriene and PAF generation and on neutrophil chemotaxis
  publication-title: World Rev. Nutr. Diet.
– volume: 129
  start-page: 39
  year: 2006
  end-page: 49
  ident: bib13
  article-title: Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma
  publication-title: Chest
– volume: 14
  start-page: 347
  year: 2011
  end-page: 353
  ident: bib5
  article-title: The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease
  publication-title: Curr. Opin. Clin. Nutr. Metab. Care
– volume: 23
  start-page: 151
  year: 2003
  end-page: 152
  ident: bib2
  article-title: Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 74
  start-page: 1922
  year: 1984
  end-page: 1933
  ident: bib30
  article-title: Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils
  publication-title: J. Clin. Invest.
– volume: 100
  start-page: 829
  year: 2008
  end-page: 833
  ident: bib7
  article-title: Effect of dietary supplementation with increasing doses of docosahexaenoic acid on neutrophil lipid composition and leukotriene production in human healthy volunteers
  publication-title: Br. J. Nutr.
– reference: National Food Institute—Technical University of Denmark (DTU). Available from:
– volume: 34
  start-page: S185
  year: 1999
  ident: bib9
  article-title: The effect of n-3 fatty acids on leukotriene formation from neutrophils in patients on hemodialysis
  publication-title: Lipids
– reference: .
– volume: 69
  start-page: 1450
  year: 2006
  end-page: 1454
  ident: bib25
  article-title: N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity
  publication-title: Kidney Int.
– volume: 107
  start-page: 499
  year: 2003
  end-page: 511
  ident: bib33
  article-title: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association
  publication-title: Circulation
– volume: 14
  start-page: S1
  year: 2007
  end-page: 113
  ident: bib1
  article-title: European guidelines on cardiovascular disease prevention in clinical practice: full text Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)
  publication-title: Eur. J. Cardiovasc. Prev. Rehabil.
– volume: 284
  start-page: 15400
  year: 2009
  end-page: 15407
  ident: bib6
  article-title: Effect of dietary fatty acids on inflammatory gene expression in healthy humans
  publication-title: J. Biol. Chem.
– volume: 56
  start-page: 59
  year: 2010
  end-page: 82
  ident: bib20
  article-title: Omega-3 fatty acids, inflammation and angiogenesis: basic mechanisms behind the cardioprotective effects of fish and fish oils
  publication-title: Cell. Mol. Biol. (Noisy-le-grand)
– volume: 34
  start-page: 317
  year: 1999
  end-page: 324
  ident: bib8
  article-title: Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men
  publication-title: Lipids
– volume: 27
  start-page: 217
  year: 1984
  end-page: 232
  ident: bib23
  article-title: Biosynthesis and biological activity of leukotriene B5
  publication-title: Prostaglandins
– volume: 18
  start-page: 51
  year: 2001
  end-page: 58
  ident: bib10
  article-title: n-3 polyunsaturated fatty acid supplementation, monocyte adhesion molecule expression and pro-inflammatory mediators in Type 2 diabetes mellitus
  publication-title: Diabet. Med.
– volume: 1
  start-page: 215
  year: 1985
  end-page: 225
  ident: bib17
  article-title: Gas chromatography–mass spectrometry method for determination of phospholipid peroxides, I: transesterification to form methyl esters
  publication-title: J. Free Radic. Biol. Med.
– volume: 83
  start-page: 456S
  year: 2006
  end-page: 460S
  ident: bib3
  article-title: Inflammation and cardiovascular disease mechanisms
  publication-title: Am. J. Clin. Nutr.
– volume: 178
  start-page: 3912
  year: 2007
  end-page: 3917
  ident: bib34
  article-title: Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation
  publication-title: J. Immunol.
– volume: 8
  start-page: S4
  year: 2007
  end-page: 10
  ident: bib21
  article-title: Incorporation and washout of n-3 polyunsaturated fatty acids after diet supplementation in clinical studies
  publication-title: J. Cardiovasc. Med. (Hagerstown)
– volume: 331
  start-page: 1111
  year: 2009
  end-page: 1117
  ident: bib22
  article-title: Differential effects of arachidonic and eicosapentaenoic acid-derived eicosanoids on polymorphonuclear transmigration across endothelial cell cultures
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 8
  start-page: S4
  issue: Suppl. 1
  year: 2007
  ident: 10.1016/j.plefa.2012.05.009_bib21
  article-title: Incorporation and washout of n-3 polyunsaturated fatty acids after diet supplementation in clinical studies
  publication-title: J. Cardiovasc. Med. (Hagerstown)
  doi: 10.2459/01.JCM.0000289269.98105.65
– volume: 28
  start-page: 71
  year: 2009
  ident: 10.1016/j.plefa.2012.05.009_bib24
  article-title: Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic alveolar macrophage cells
  publication-title: Clin. Nutr.
  doi: 10.1016/j.clnu.2008.10.012
– volume: 18
  start-page: 51
  year: 2001
  ident: 10.1016/j.plefa.2012.05.009_bib10
  article-title: n-3 polyunsaturated fatty acid supplementation, monocyte adhesion molecule expression and pro-inflammatory mediators in Type 2 diabetes mellitus
  publication-title: Diabet. Med.
  doi: 10.1046/j.1464-5491.2001.00410.x
– volume: 134
  start-page: 671
  year: 1989
  ident: 10.1016/j.plefa.2012.05.009_bib27
  article-title: In vivo chemotaxis of bovine neutrophils induced by 5-lipoxygenase metabolites of arachidonic and eicosapentaenoic acid
  publication-title: Am. J. Pathol.
– volume: 74
  start-page: 1922
  year: 1984
  ident: 10.1016/j.plefa.2012.05.009_bib30
  article-title: Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI111612
– volume: 14
  start-page: S1
  issue: Suppl. 2
  year: 2007
  ident: 10.1016/j.plefa.2012.05.009_bib1
  publication-title: Eur. J. Cardiovasc. Prev. Rehabil.
  doi: 10.1097/01.hjr.0000277983.23934.c9
– year: 1987
  ident: 10.1016/j.plefa.2012.05.009_bib18
– volume: 34
  start-page: S185
  issue: Suppl.
  year: 1999
  ident: 10.1016/j.plefa.2012.05.009_bib9
  article-title: The effect of n-3 fatty acids on leukotriene formation from neutrophils in patients on hemodialysis
  publication-title: Lipids
  doi: 10.1007/BF02562283
– volume: 268
  start-page: 9280
  year: 1993
  ident: 10.1016/j.plefa.2012.05.009_bib28
  article-title: Stimulation of human neutrophils by 5-oxo-6,8,11,14-eicosatetraenoic acid by a mechanism independent of the leukotriene B4 receptor
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)98347-X
– volume: 34
  start-page: 317
  year: 1999
  ident: 10.1016/j.plefa.2012.05.009_bib8
  article-title: Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men
  publication-title: Lipids
  doi: 10.1007/s11745-999-0369-5
– volume: 277
  start-page: 31459
  year: 2002
  ident: 10.1016/j.plefa.2012.05.009_bib29
  article-title: Identification of a novel human eicosanoid receptor coupled to G(i/o)
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M203194200
– volume: 284
  start-page: 15400
  year: 2009
  ident: 10.1016/j.plefa.2012.05.009_bib6
  article-title: Effect of dietary fatty acids on inflammatory gene expression in healthy humans
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M109.004861
– volume: 100
  start-page: 829
  year: 2008
  ident: 10.1016/j.plefa.2012.05.009_bib7
  article-title: Effect of dietary supplementation with increasing doses of docosahexaenoic acid on neutrophil lipid composition and leukotriene production in human healthy volunteers
  publication-title: Br. J. Nutr.
  doi: 10.1017/S0007114508923692
– volume: 32
  start-page: 15
  year: 2012
  ident: 10.1016/j.plefa.2012.05.009_bib14
  article-title: Low-dose fish oil supplementation increases serum adiponectin without affecting inflammatory markers in overweight subjects
  publication-title: Nutr. Res.
  doi: 10.1016/j.nutres.2011.12.007
– ident: 10.1016/j.plefa.2012.05.009_bib15
– volume: 23
  start-page: 151
  year: 2003
  ident: 10.1016/j.plefa.2012.05.009_bib2
  article-title: Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/01.ATV.0000057393.97337.AE
– volume: 83
  start-page: 456S
  year: 2006
  ident: 10.1016/j.plefa.2012.05.009_bib3
  article-title: Inflammation and cardiovascular disease mechanisms
  publication-title: Am. J. Clin. Nutr.
  doi: 10.1093/ajcn/83.2.456S
– volume: 311
  start-page: 158
  year: 1995
  ident: 10.1016/j.plefa.2012.05.009_bib16
  article-title: Waist circumference as a measure for indicating need for weight management
  publication-title: Br. Med. J.
  doi: 10.1136/bmj.311.6998.158
– volume: 27
  start-page: 217
  year: 1984
  ident: 10.1016/j.plefa.2012.05.009_bib23
  article-title: Biosynthesis and biological activity of leukotriene B5
  publication-title: Prostaglandins
  doi: 10.1016/0090-6980(84)90075-3
– volume: 312
  start-page: 1217
  year: 1985
  ident: 10.1016/j.plefa.2012.05.009_bib12
  article-title: Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM198505093121903
– volume: 1
  start-page: 215
  year: 1985
  ident: 10.1016/j.plefa.2012.05.009_bib17
  article-title: Gas chromatography–mass spectrometry method for determination of phospholipid peroxides, I: transesterification to form methyl esters
  publication-title: J. Free Radic. Biol. Med.
  doi: 10.1016/0748-5514(85)90121-7
– volume: 14
  start-page: 347
  year: 2011
  ident: 10.1016/j.plefa.2012.05.009_bib5
  article-title: The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease
  publication-title: Curr. Opin. Clin. Nutr. Metab. Care
  doi: 10.1097/MCO.0b013e32834777fa
– volume: 36
  start-page: 2590
  year: 1995
  ident: 10.1016/j.plefa.2012.05.009_bib31
  article-title: Formation of a 5-oxo metabolite of 5,8,11,14,17-eicosapentaenoic acid and its effects on human neutrophils and eosinophils
  publication-title: J. Lipid Res.
  doi: 10.1016/S0022-2275(20)41095-8
– volume: 129
  start-page: 39
  year: 2006
  ident: 10.1016/j.plefa.2012.05.009_bib13
  article-title: Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma
  publication-title: Chest
  doi: 10.1378/chest.129.1.39
– volume: 56
  start-page: 59
  year: 2010
  ident: 10.1016/j.plefa.2012.05.009_bib20
  article-title: Omega-3 fatty acids, inflammation and angiogenesis: basic mechanisms behind the cardioprotective effects of fish and fish oils
  publication-title: Cell. Mol. Biol. (Noisy-le-grand)
– volume: 107
  start-page: 499
  year: 2003
  ident: 10.1016/j.plefa.2012.05.009_bib33
  article-title: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000052939.59093.45
– volume: 41
  start-page: 30
  year: 2011
  ident: 10.1016/j.plefa.2012.05.009_bib32
  article-title: Body mass index is associated with leukotriene inflammation in asthmatics
  publication-title: Eur. J. Clin. Invest.
  doi: 10.1111/j.1365-2362.2010.02371.x
– volume: 69
  start-page: 1450
  year: 2006
  ident: 10.1016/j.plefa.2012.05.009_bib25
  article-title: N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity
  publication-title: Kidney Int.
  doi: 10.1038/sj.ki.5000291
– volume: 331
  start-page: 1111
  year: 2009
  ident: 10.1016/j.plefa.2012.05.009_bib22
  article-title: Differential effects of arachidonic and eicosapentaenoic acid-derived eicosanoids on polymorphonuclear transmigration across endothelial cell cultures
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.109.157891
– volume: 23
  start-page: 41
  year: 2009
  ident: 10.1016/j.plefa.2012.05.009_bib4
  article-title: Leukotriene signaling in atherosclerosis and ischemia
  publication-title: Cardiovasc. Drugs Ther.
  doi: 10.1007/s10557-008-6140-9
– volume: 66
  start-page: 391
  year: 1991
  ident: 10.1016/j.plefa.2012.05.009_bib19
  article-title: Effects of dietary fish oil on leukocyte leukotriene and PAF generation and on neutrophil chemotaxis
  publication-title: World Rev. Nutr. Diet.
  doi: 10.1159/000419307
– volume: 178
  start-page: 3912
  year: 2007
  ident: 10.1016/j.plefa.2012.05.009_bib34
  article-title: Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.178.6.3912
– volume: 6
  start-page: 402
  year: 1986
  ident: 10.1016/j.plefa.2012.05.009_bib11
  article-title: Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid
  publication-title: J. Clin. Immunol.
  doi: 10.1007/BF00915380
– volume: 85
  start-page: 37
  year: 2011
  ident: 10.1016/j.plefa.2012.05.009_bib26
  article-title: The effect of n-3 polyunsaturated fatty acids on leukotriene B(4) and leukotriene B(5) production from stimulated neutrophil granulocytes in patients with chronic kidney disease
  publication-title: Prostaglandins Leukot. Essent. Fatty Acids
  doi: 10.1016/j.plefa.2011.04.004
SSID ssj0002114
Score 2.1151726
Snippet Marine n-3 polyunsaturated fatty acids (PUFA) have a variety of anti-inflammatory properties. This study evaluated the effect of n-3 PUFA in a low, but...
Abstract Introduction Marine n-3 polyunsaturated fatty acids (PUFA) have a variety of anti-inflammatory properties. This study evaluated the effect of n-3 PUFA...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 43
SubjectTerms 5-Lipoxygenase
Advanced Basic Science
Aged
Anti-Inflammatory Agents - administration & dosage
Arachidonate 5-Lipoxygenase - metabolism
Cardiotonic Agents - administration & dosage
Cell Membrane - metabolism
Double-Blind Method
Eicosapentaenoic Acid - analogs & derivatives
Eicosapentaenoic Acid - biosynthesis
Endocrinology & Metabolism
Fatty Acids, Omega-3 - administration & dosage
Female
Humans
Hydroxyeicosatetraenoic Acids - biosynthesis
Leukotriene B4 - analogs & derivatives
Leukotriene B4 - biosynthesis
Leukotrienes
Male
Marine n-3 polyunsaturated fatty acids
Middle Aged
Multivariate Analysis
Neutrophils - metabolism
Obesity, Abdominal - drug therapy
Obesity, Abdominal - pathology
Overweight - drug therapy
Overweight - pathology
Treatment Outcome
Title The effect of low-dose marine n-3 fatty acids on the biosynthesis of pro-inflammatory 5-lipoxygenase pathway metabolites in overweight subjects: A randomized controlled trial
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0952327812000890
https://www.clinicalkey.es/playcontent/1-s2.0-S0952327812000890
https://dx.doi.org/10.1016/j.plefa.2012.05.009
https://www.ncbi.nlm.nih.gov/pubmed/22748976
https://www.proquest.com/docview/1027833469
Volume 87
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELbKVkK8IGg5lsJqkBBPmM0mzsXbakW1HK0QUKlvluNDSpVjhbNqwwM_id_IOMdKCFok3pzIEyfxHJ_HM2NCXugg9AwTEuWbScqUUChS4YIiltcIT32llHPon5xG6zP2_jw83yOrMRfGhVUOur_X6Z22Hu7Mh7853-T5_AuCA4QDMVooZ8hSXLfv-0EahROyv3z3YX26U8i4xmF9yT2fOoKx-FAX5rUptHH1h5xP0LlX0usM1HUAtDNEx_fI3QFBwrJ_yftkT1cH5HBZ4eq5bOEldDGdnbP8gNw-GbbOD8lPZAjoozegNlDUl1TVVkMpXP4fVDQAI5qmBSFzZaGuAKEhZHlt2wpbNreODN-OIk8iG5Xd9jyEtMg39VWLfIj2ENwBx5eihVI3yF0uv9lCXkHdhV87PwDYbeZcP_YNLAHtpKrL_LtWMITMF9jsDhJ5QM6O335drelwWAOVLIoaGhoTeEYFOkyMRJvvy5CpLI2M8qSfSoW4L3OpiYny0wRBg5cJJAhE5ulEaWw_JJOqrvRjAkogik0l8w3iyVgvUhbHImG4FE08oRNvSvxxhrgcKpm7AzUKPoasXfBuWrmbVu6FHB83Ja92RJu-kMfN3dk49XzMUUWtytHQ3EwW_41M20EzWL7gFjvzP7h3SqId5W8C8O8hn4-cyVE1uP0eUel6i0O5XeUgYBH2edSz7O7Tfd-VHYqjJ_877BG54676yOWnZNJ82-pniM-abEZuvf6xmKEUrj5__DQbpPEXNks9MA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIgEXBC2P5TlIiBNms4nz4raqqBbo9kIr9WY5sSOl2iQrnFWbHvhJ_EZmnGQRghaJm7XrWSfr8czn8Tdjxt6YIPQKoXJc3yLnQiuNSyqcccTyBuGpr7WmgP7yOFqcis9n4dkOOxhzYYhWOdj-3qY7az18Mh3-zem6LKdfERwgHIjRQ5EjS3HffkuEQUy8vvfff_E8cIcj-oJ7PqfuY-khR_Jar0xB1YcoIkjBlfQ693Qd_HRu6PA-uzfgR5j3j_iA7Zh6j-3Pa9w7Vx28BcfodKHyPXZ7ORyc77MfqA7QczegKWDVXHDdWAOVouw_qHkAhWrbDlReagtNDQgMISsb29XYsqUlMXw6jhqJSlS5w3kI-apcN5cdaiF6Q6DrjS9UB5VpUbcou9lCWUPjyNcUBQC7ySjwYz_AHNBL6qYqr4yGgTC_wqa7RuQhOz38eHKw4MNVDTwXUdTysCgCr9CBCZMiR4_v56HQWRoV2sv9NNeI-jJKTEy0nyYIGbxMoUCgMs8k2mD7Edutm9o8YaAVYtg0F36BaDI2s1TEsUoEbkQTT5nEmzB_nCGZD3XM6TqNlRwJa-fSTaukaZVeKPHnJuzdVmjdl_G4ubsYp16OGapoUyW6mZvF4r-JGTvYBStn0mJn-YfuTli0lfxN_f895OtRMyUaBjrtUbVpNjgUnSkHgYiwz-NeZbev7vtUdCiOnv7vsK_YncXJ8kgefTr-8ozdpW96DvNzttt-25gXiNTa7KVbiT8BC7o8Zg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effect+of+low-dose+marine+n-3+fatty+acids+on+the+biosynthesis+of+pro-inflammatory+5-lipoxygenase+pathway+metabolites+in+overweight+subjects%3A+A+randomized+controlled+trial&rft.jtitle=Prostaglandins%2C+leukotrienes+and+essential+fatty+acids&rft.au=Nielsen%2C+M.S&rft.au=Gammelmark%2C+A&rft.au=Madsen%2C+T&rft.au=Obel%2C+T&rft.date=2012-07-01&rft.issn=0952-3278&rft.volume=87&rft.issue=1&rft.spage=43&rft.epage=48&rft_id=info:doi/10.1016%2Fj.plefa.2012.05.009&rft.externalDBID=ECK1-s2.0-S0952327812000890&rft.externalDocID=1_s2_0_S0952327812000890
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09523278%2FS0952327812X0005X%2Fcov150h.gif